Des acteurs près de chez vous
Accueil > 44 measures > Measure n°30
Agrandir la taille des caractères Réduire la taille des caractères Envoyer cette page Imprimer

Measure n°30Version française

High-speed genotyping

Opportunity

The high-speed genotyping of patients and controls should enable genetic traits of vulnerability to Alzheimer’s disease to be identified. A project has already been launched in the UK, which should reach completion in summer 2008. A large-scale project should be launched in France to exploit existing work, in particular projects in Lille and Rouen, which could also be completed by the summer. A feature and strength of French research is that we have a large number of cases (2500) and controls (10000).
This subject is particularly important for research into young patients.

Implementation details

This major genotyping project, using a genome-scan approach, can only be conducted quickly with the help of the National Genotyping Centre (Centre national de génotypage).

Actors

Lead supervision : the Foundation for Scientific Cooperation (Fondation de Coopération Scientifique, FCS)

Schedule

From 2008.

Funding

2008: €3.2 million; 2009: €2.15 million. Total commitment over the period of €5.4 million

Foundation for Scientific Cooperation.

Evaluation

previous next